Testing XTL6001 in healthy and obese adults
Part of Hormones & metabolism clinical trials.
This early-stage trial tests a new medication (XTL6001) in healthy and obese adults to see if it is safe. It is for people who are not diabetic, have no history of certain stomach, pancreas, or gallbladder problems, and have a BMI up to 40.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 64 years old.
- Have a body mass index (BMI) from 18.5 to 39.9 kg/m² (normal weight to obese).
- Weigh at least 110 pounds for men or 99 pounds for women.
- No history of diabetes, high blood sugar, or any type of pancreatitis.
- No current gallbladder disease, recent cancer, or family history of certain thyroid cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called DA-302168S to help people lose weight. You may qualify if you're overweight or obese and meet certain health requirements.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
Hear when a new Weight Management in Adult Patients With Obesity or Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.